Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens
- 5 February 2008
- Vol. 371 (1), 98-107
- https://doi.org/10.1016/j.virol.2007.09.029
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Major Neutralizing Sites on Vaccinia Virus Glycoprotein B5 Are Exposed Differently on Variola Virus Ortholog B6Journal of Virology, 2007
- A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boostVaccine, 2007
- Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccineVaccine, 2005
- Identification of Two Neutralizing Regions on the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Produced from the Mammalian Expression SystemJournal of Virology, 2005
- ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defenseInternational Journal of Infectious Diseases, 2004
- Dose-Related Effects of Smallpox VaccineNew England Journal of Medicine, 2002
- Codon usage limitation in the expression of HIV-1 envelope glycoproteinCurrent Biology, 1996
- Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola virusesVirus Research, 1995
- Functional organization of variola major and vaccinia virus genomesVirus Genes, 1995
- Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.The Journal of Experimental Medicine, 1994